| Old Articles: <Older 1491-1500 Newer> |
|---|
 |
The Motley Fool
April 5, 2004
Ben McClure |
An Overbaked Apple Apple's share price is overdone.   |
The Motley Fool
April 5, 2004
Charly Travers |
A Biotech's Transition to Drugs A deal with Roche gives ArQule's drug program a leg up. ArQule has spent the last year transitioning from a services company into a drug developer. Last week's deal with Roche could signify that the transition is complete. |
The Motley Fool
April 5, 2004
Dave Marino-Nachison |
Maytag Makes a Move Shares of the appliance maker rise in anticipation of improved Hoover sales. |
The Motley Fool
April 5, 2004
Rich Smith |
Allegheny's Steel Woes With the steel industry reporting record profits, Allegheny Technologies reports losses. |
The Motley Fool
April 5, 2004
Dave Marino-Nachison |
Finally, Eckerd Sells J.C. Penney's drugstore operation will be split between CVS and Jean Coutu. |
The Motley Fool
April 5, 2004
Selena Maranjian |
Accrual Accounting Explained It's important to understand how the companies you hold stock in are booking their sales. |
The Motley Fool
April 2, 2004
Mark Mahorney |
Atkins Boosts Chicken Business The poultry industry is feeling the squeeze on both ends, but the diet provides relief. |
The Motley Fool
April 2, 2004
Brian Gorman |
Bayer's Food Fight Bayer's recent U.K. troubles reflect Europe's continued distaste for genetically modified foods. |
The Motley Fool
April 2, 2004
Dave Marino-Nachison |
Darden's Olive Garden Grows Shares of Darden Restaurants, owner of the Olive Garden and Red Lobster chains among others, fell yesterday (they were about flat in trading today) on news of continued same-restaurant sales declines |
The Motley Fool
April 2, 2004
Dave Marino-Nachison |
American Eagle Eyes Summer The casual apparel retailer's shares keep rising as warm weather nears. |
| <Older 1491-1500 Newer> Return to current articles. |
